300740 SYoung Group
- 18.71
- +0.11+0.59%
SYoung Group News
Shuiyang Co., Ltd. (300740.SZ): The Yumifang brand currently focuses on comprehensive brand upgrading to complete mental correction, grooming and product system iteration
Gelonghui, May 10 | Shuiyang Co., Ltd. (300740.SZ) said on the investor interactive platform that the Yunifang brand is currently focusing on comprehensive brand upgrading to complete mental correction and product system iteration. On May 9, 2024, a press conference on the new upgrade of the brand “2+3 Oriental Skin Formula” was held, and a new big product, the “Black Ginseng Collagen Bottle”, was launched. Stay tuned for more details on the upgrade, and stay tuned for official news from the official Yunifang account, flagship store, etc.
Shuiyang Co., Ltd. (300740.SZ): AI technology has been used to assist in handling after-sales issues such as ownership, evaluation labeling, etc.
Gelonghui, May 10, 丨 Shuiyang Co., Ltd. (300740.SZ) said on the investor interactive platform that the company has not yet connected to the KIMI system and currently mainly uses GPT4. In terms of solving after-sales problems, AI technology has been used to assist in handling matters such as the attribution of after-sales issues, evaluation labels, etc.
Shuyang Co., Ltd. (300740.SZ): The tetrahydropyrimidine (ecdoine) strain developed in collaboration with Jiangnan University can be mass-produced
Gelonghui, May 10 | Shuiyang Co., Ltd. (300740.SZ) said on the investor interactive platform that in the field of synthetic biology, the company cooperated with Academician Chen Jian of Jiangnan University earlier and hired Academician Chen Jian as the chief scientist in 2022, and has obtained 11 patented technologies. Among them, Jiangnan University transferred 6 patents related to the use of synthetic biology to produce small-molecule hyaluronic acid, independently developed and obtained 5 patents for raw material preparation, testing and application, and applied the relevant technology to products such as Yunifang micro 800 and micro 400 hyaluronic acid subserums. Furthermore, tetrahydropyrimidine developed in collaboration with Kangnam University (Ike
SYoung Group Co., Ltd. (SZSE:300740) Analysts Just Trimmed Their Revenue Forecasts By 18%
Today is shaping up negative for SYoung Group Co., Ltd. (SZSE:300740) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. This report focused on reve
Shuiyang Co., Ltd. (300740.SZ) announced first-quarter results, net profit of 40.1 million yuan, a year-on-year decrease of 23.25%
Shuiyang Co., Ltd. (300740.SZ) disclosed its report for the first quarter of 2024. The company achieved revenue of 10 during the reporting period...
Shuyang Co., Ltd. (300740.SZ): No AI technology has been used to participate in R&D
On April 7, Gelonghui Co., Ltd. (300740.SZ) said on the investor interactive platform that the company adheres to the “R&D Empowers Brand” strategy and continues to increase investment in R&D. Domestic and external self-research projects are being carried out simultaneously with industry, education and research, and has now successfully achieved independent control of various raw materials. “Pyrroloquinoline Quinone Disodium Salt” (PQQ disodium salt for short), the first domestic ingredient with the same origin as cosmetics and food, has been approved by the State Food and Drug Administration; China's unique new ingredient “black ginseng extract” has been registered; the company has not yet used AI technology to participate in R&D, but it will continue to increase investment in R&D to promote cutting-edge scientific research and innovation
Earnings Tell The Story For SYoung Group Co., Ltd. (SZSE:300740) As Its Stock Soars 26%
SYoung Group Co., Ltd. (SZSE:300740) shares have had a really impressive month, gaining 26% after a shaky period beforehand. The last 30 days bring the annual gain to a very sharp 35%. Following
SYoung Group (SZSE:300740) Hasn't Managed To Accelerate Its Returns
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and sec
At CN¥17.16, Is SYoung Group Co., Ltd. (SZSE:300740) Worth Looking At Closely?
SYoung Group Co., Ltd. (SZSE:300740), might not be a large cap stock, but it saw a significant share price rise of 23% in the past couple of months on the SZSE. While good news for shareholders,
Shuiyang Co., Ltd. (300740.SZ): As of February 20, the total number of shareholders of the company was more than 18,000
On February 26, Gelonghui Co., Ltd. (300740.SZ) said on the investor interactive platform that as of February 20, the total number of shareholders of the company was over 18,000.
Retail Investors Among SYoung Group Co., Ltd.'s (SZSE:300740) Largest Stockholders and Were Hit After Last Week's 6.7% Price Drop
Key Insights SYoung Group's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public The top 4 shareholders own 51% of the company
Shuiyang Co., Ltd. (300740.SZ): 2023 net profit pre-increased 124%-156%
On January 18, Ge Longhui Co., Ltd. (300740.SZ) announced the 2023 annual results forecast. Net profit attributable to shareholders of listed companies during the reporting period was between RMB 280 million and RMB 320 million, up 124% — 156% from the same period last year; net profit after deducting non-recurring profit and loss was between RMB 260 million and RMB 30,000, up 169% to 210% over the same period last year. During the reporting period, the multi-level brand matrix system for the company's independent brands was further improved, brand assets continued to accumulate, the agency brand business entered a healthy track, and the overall business and product structure were further improved
Water Yang Co., Ltd. (300740.SZ): Currently, the design team uses AI to create content, and the technical team uses AI to assist in code development
Gelonghui January 15 丨 An investor asked Shuiyang Co., Ltd. (300740.SZ) on the investor interactive platform, “What are the company's Internet attributes? Can the development of the business be connected with artificial intelligence?” The company replied that the company adheres to the dual technology empowerment strategy of “R&D empowers brands, digitally empowers organizations”, and that the company's technical team continues to iterate on the digital beauty platform with collaboration and digital management as the core goals. The company is also actively exploring AI intelligence. Currently, the design team is already using AI for content creation, and the technical team is using AI to assist in code development. In the future, it will also follow its own business pace and
Shuiyang Co., Ltd. (300740.SZ): There are currently no recombinant human collagen-related products
Gelonghui January 15 丨 Some investors asked Shuiyang Co., Ltd. (300740.SZ) on the investor interactive platform, “Does the company have recombinant human collagen products, or are there any considerations in this regard in the future”. The company replied that the company currently has no recombinant human collagen-related products, and the company has always adhered to the strategy of “R&D to empower brands”, and will continue to increase investment in R&D to promote cutting-edge scientific research, innovative raw material development, and product development services. Please continue to pay attention to the information publicly disclosed by the company.
Guotai Junan: Leading domestic cosmetics brands have entered a stage of rapid increase in market share
Guotai Junan released a research report saying that it continues to be optimistic that leading domestic cosmetics brands will continue to promote product innovation on the basis of more efficient market feedback and channel operations, and enter a stage where market share is rapidly increasing.
Declining Stock and Decent Financials: Is The Market Wrong About SYoung Group Co., Ltd. (SZSE:300740)?
With its stock down 20% over the past three months, it is easy to disregard SYoung Group (SZSE:300740). However, stock prices are usually driven by a company's financials over the long term, which i
Guoyuan Securities: The Double Eleven War ended, domestic beauty brands performed well, and the Douyin channel showed high growth
The bank maintains the industry's “recommended” rating. Focus on Plarial (603605.SH), Giant Biotech (02367), Bettany (300957.SZ), Freda (600223.SH), Shanghai Jiahua (600315.SH), and Shuiyang Co., Ltd. (300740.SZ).
Guotai Junan reviews the first stage of sales of cosmetics in Double Eleven: the ranking of domestic products has increased significantly, Polearia (603605.SH) and Giants (02367) stand out
The performance of the industry in the first phase of Double Eleven was lackluster, but the ranking of domestic goods improved markedly. Polaire climbed to the top of the multi-platform beauty category, and continued to be optimistic that domestic brands entered a stage of rapid increase in market share after boosting product innovation.
Summary of the third quarterly report of Guotai Junan Cosmetics: the lack of catalysts in the off-season is expected to continue to increase the share of leading brands
The 23Q3 off-season cosmetics company had zero +3% year-on-year ratio, and Douyin maintained a relatively rapid growth rate among online platforms.
Is SYoung Group (SZSE:300740) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it might be obvious
Analysis
Price Target
No Data
